Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment
Clinical trial NCT04971928 · COMPLETED
Trial details
- NCT number
- NCT04971928
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-07
- Primary completion
- 2022-05-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.